vaccines

Booming biz raises questions about vax legal shield
Booming biz raises questions about vax legal shield
Fierce Biotech
vaccines
Flag link:
Novavax sees potential in lab-stage flu vaccine
Novavax sees potential in lab-stage flu vaccine
Yahoo/AP
Novavax
Flu
vaccines
Flag link:
Vaccine Firm Genocea Gets $23 Million Injection
Vaccine Firm Genocea Gets $23 Million Injection
New York Times,NY
vaccines
Genocea Biosciences
GSK
Flag link:
Biotechnology: The New Defensive Sector That's Set to Rise?
Biotechnology: The New Defensive Sector That's Set to Rise?
Seeking Alpha
biotech
metabolic syndrome
vaccines
infection diseases
Flag link:
Crucell posts 4Q profit on vaccine sales
Crucell posts 4Q profit on vaccine sales
Yahoo/AP
vaccines
Crucell
earnings
Flag link:
Last Call: Novartis Gets Vaccine Bricks & Mortar Money
Last Call: Novartis Gets Vaccine Bricks & Mortar Money
InVivo
vaccines
Novartis
Flag link:
Emergent BioSolutions: Still a Bit Risky
Emergent BioSolutions: Still a Bit Risky
Seeking Alpha
Emergent BioSolutions
vaccines
Flag link:
HHS, Novartis ink $486M vaccine deal
HHS, Novartis ink $486M vaccine deal
Fierce Pharma
Novartis
vaccines
Flag link:
Wyeth exec: Nontraditional products fueling growth. Diversification continues as biotech, vaccines grow faster than traditional drugs.
Wyeth exec: Nontraditional products fueling growth. Diversification continues as biotech, vaccines grow faster than traditional drugs.
Yahoo/AP
Wyeth
vaccines
biotech
Flag link:
Wyeth Targets Crucell Vaccines With $1.35 Billion Bid
Wyeth Targets Crucell Vaccines With $1.35 Billion Bid
buyouts
Wyeth
vaccines
Crucell
buyouts
Flag link:
Pfizer Takes Comml Licenses For Some Cytos Vaccines
Pfizer Takes Comml Licenses For Some Cytos Vaccines
CNN Money
Pfizer
Cytos Biotechnology
vaccines
Flag link:
Novartis Buys License to AlphaVax’s Cytomegalovirus Vaccine
Novartis Buys License to AlphaVax’s Cytomegalovirus Vaccine
Bloomberg
Novartis
CMV
vaccines
AlphaVax
Flag link:

Pages